Abstract
Research has been inconclusive as to whether stimulant treatment causes or exacerbates sleep problems in adolescents with ADHD. This study examined sleep differences in adolescents with ADHD as a function of stimulant use. Participants were adolescents with ADHD (N = 159, ages 12–14). Parents reported on receipt of stimulant treatment (n = 92, 57.86%; n = 47 amphetamines, n = 45 methylphenidate). Adolescents wore actigraphs and completed daily diaries assessing sleep and daily use of stimulants for 2 weeks. Sleep parameters included daily-reported bedtime, sleep onset latency (SOL), sleep duration, daytime sleepiness, and difficulty waking the following morning; and actigraphy-measured sleep onset time, total time in bed, and sleep efficiency. We estimated between- and within-individual associations between stimulant medication use and sleep indices with all stimulants, after removing adolescents using sleep aids and weekend days, and as a function of stimulant type. Adolescent sleep did not differ between those receiving and not receiving stimulant treatment. Within individuals using stimulants, we largely observed no significant differences between medicated and unmedicated days, though findings were most often significant for school days only. Small effects were found indicating longer SOL, later sleep onset time, and more daytime sleepiness related to medication use. In contrast, there were slight improvements to sleep duration and sleep efficiency related to methylphenidate use, though methylphenidate was also associated with later sleep onset time and more daytime sleepiness. Given the inconsistent and small effects, findings suggest that stimulant medication may impact sleep, but does not appear to be a primary contributor to sleep problems in adolescents with ADHD.
Similar content being viewed by others
Data availability
Data preparation and descriptive statistics were done in SPSS 28 and SAS 9.4. MPlus 8.8 was used for all modeling. Data and code are available from the corresponding author upon reasonable request and execution of a data use agreement.
References
Cortese S (2015) Sleep and ADHD: what we know and what we do not know. Sleep Med 16:5–6
Owens J, Gruber R, Brown T et al (2013) Future research directions in sleep and ADHD: report of a consensus working group. J Atten Disord 17(7):550–564
Kirov R, Brand S (2014) Sleep problems and their effect in ADHD. Expert Rev Neurother 14(3):287–299
Yektaş Ç, Tufan AE, Sarıgedik E (2020) Sleep habits of children diagnosed with attention/deficit/hyperactivity disorder and effects of treatment on sleep related parameters. Asian J Psychiatr 52:102045
Becker SP (2020) ADHD and sleep: Recent advances and future directions. Curr Opin Psychol 34:50–56. https://doi.org/10.1016/j.copsyc.2019.09.006
O’Brien LM, Ivanenko A, Crabtree VM et al (2003) The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder. Sleep Med 4(4):309–316
Sanabra M, Gómez-Hinojosa T, Alcover C, Sans O, Alda JA (2021) Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD). Sleep Biol Rhythms 19(1):69–77
Cortese S, Faraone SV, Konofal E, Lecendreux M (2009) Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry 48(9):894–908
Chen M, Wardlaw M, Stein MA (2019) ADHD medications and sleep. Elsevier 11:151–173
Stein MA, Zulauf-McCurdy C, DelRosso LM (2022) Attention Deficit Hyperactivity Disorder Medications and Sleep. Child Adol Psychiat Clin 31(3):499–514
Becker SP, Froehlich TE, Epstein JN (2016) Effects of methylphenidate on sleep functioning in children with attention-deficit/hyperactivity disorder. J develop behav pediat JDBP 37(5):395
Corkum P, Begum EA, Rusak B et al (2020) The effects of extended-release stimulant medication on sleep in children with ADHD. J Canad Acad Child Adoles Psychiatry 29(1):33
Davidson F, Rigney G, Rusak B, Chambers C, Rajda M, Corkum P (2021) Sleep variables as predictors of treatment effectiveness and side effects of stimulant medication in newly diagnosed children with attention-deficit/hyperactivity disorder. J Dev Behav Pediatr 42(1):1–8
Galland BC, Tripp EG, Taylor BJ (2010) The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case–control study. J Sleep Res 19(2):366–373
Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA (2009) Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(3):233–239
Hvolby A (2015) Associations of sleep disturbance with ADHD: implications for treatment. ADHD Attent Deficit and Hyperact Disord 7(1):1–18
Lee SH, Seo WS, Sung HM et al (2012) Effect of methylphenidate on sleep parameters in children with ADHD. Psychiatry Investig 9(4):384
Owens J, Weiss M, Nordbrock E et al (2016) Effect of Aptensio XR (methylphenidate HCl extended-release) capsules on sleep in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 26(10):873–881
Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD (2015) Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics 136(6):1144–1153
Ironside S, Davidson F, Corkum P (2010) Circadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorder. J Sleep Res 19(4):546–551
Morash-Conway J, Gendron M, Corkum P (2017) The role of sleep quality and quantity in moderating the effectiveness of medication in the treatment of children with ADHD. ADHD Attent Deficit and Hyperact Disord 9(1):31–38
Wigal SB, Wong AA, Jun A, Stehli A, Steinberg-Epstein R, Lerner MA (2012) Adverse events in medication treatment-naive children with attention-deficit/hyperactivity disorder: results from a small, controlled trial of lisdexamfetamine dimesylate. J Child Adolesc Psychopharmacol 22(2):149–156
Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B (2011) Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry Hum Dev 42(3):257–269
Efron D, Jarman F, Barker M (1997) Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 100(4):662–666
Ashkenasi A (2011) Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder. Pediatr Neurol 45(6):381–386
Giblin JM, Strobel AL (2011) Effect of lisdexamfetamine dimesylate on sleep in children with ADHD. J Atten Disord 15(6):491–498
Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA (1995) Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics 96(2):320–325
Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL (2009) Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD. J Atten Disord 12(4):308–315
Cataldo M, Donnelly G, Cutler AJ et al (2022) Analysis of daily sleep diary measures from multilayer extended-release methylphenidate (prc-063) studies in children and adults With ADHD. J Attent Disord. 26:10870
Surman CB, Roth T (2011) Impact of stimulant pharmacotherapy on sleep quality: post hoc analyses of 2 large, double-blind, randomized, placebo-controlled trials. J Clin Psychiatry 72(7):8683
Weiss MD, Surman C, Khullar A et al (2021) Effect of a multilayer, extended-release methylphenidate formulation (prc-063) on sleep in adolescents with attention-deficit/hyperactivity disorder: a randomized, double-blind, fixed-dose, placebo-controlled trial followed by a 6-month open-label follow-Up. J Child Adolesc Psychopharmacol 31(9):623–630
Laberge L, Petit D, Simard C, Vitaro F, Tremblay RE, Montplaisir J (2001) Development of sleep patterns in early adolescence. J Sleep Res 10(1):59–67
Calhoun SL, Fernandez-Mendoza J, Vgontzas AN, Liao D, Bixler EO (2014) Prevalence of insomnia symptoms in a general population sample of young children and preadolescents: gender effects. Sleep Med 15(1):91–95
Safer DJ (2016) Recent trends in stimulant usage. J Atten Disord 20(6):471–477
Becker SP, Langberg JM, Eadeh HM, Isaacson PA, Bourchtein E (2019) Sleep and daytime sleepiness in adolescents with and without ADHD: Differences across ratings, daily diary, and actigraphy. J Child Psychol Psychiatry 60(9):1021–1031
Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, Loo SK, Carlson CL, McBurnett K, Lahey BB (2012) Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol 121(4):991
Weller EB, Weller R, Rooney MT, Fristad MA (1999) Children’s Interview for Psychiatric Syndromes (ChIPS). Amer Psychiat Assoc. 39:76
Hoagwood KE, Jensen PS, Arnold LE et al (2004) Reliability of the services for children and adolescents–parent interview. J Am Acad Child Adolesc Psychiatry 43(11):1345–1354
Sadeh A, Sharkey KM, Carskadon MA (1994) Activity-based sleep-wake identification: An empirical test of methodological issues. Sleep 17:201–207
Short MA, Gradisar M, Lack LC, Wright H, Carskadon MA (2012) The discrepancy between actigraphic and sleep diary measures of sleep in adolescents. Sleep Med 13(4):378–384
Hamaker EL, Asparouhov T, Brose A, Schmiedek F, Muthén B (2018) At the frontiers of modeling intensive longitudinal data: Dynamic structural equation models for the affective measurements from the COGITO study. Multivar Behav Res 53(6):820–841
McNeish D, Hamaker EL (2020) A primer on two-level dynamic structural equation models for intensive longitudinal data in Mplus. Psychol Methods 25(5):610
Gould ON, Doucette C (2018) Self-management of adherence to prescribed stimulants in college students with. J Atten Disord 22(349):355
Marcus SC, Durkin M (2011) Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. J Amer Acad Child Adolescent Psychiat. 50(5):480–489
Sciberras E, Mulraney M, Mensah F, Oberklaid F, Efron D, Hiscock H (2020) Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD: a randomised controlled trial. Psychol Med 50(2):210–219
Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD (2006) Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 45(5):512–519
Smith ZR, Langberg JM, Cusick CN, Green CD, Becker SP (2020) Academic motivation deficits in adolescents with ADHD and associations with academic functioning. J Abnorm Child Psychol 48:237–249
Sibley MH, Altszuler AR, Morrow AS, Merrill BM (2014) Mapping the academic problem behaviors of adolescents with ADHD. Sch Psychol Q 29(4):422
Bunford N, Evans SW, Langberg JM (2018) Emotion dysregulation is associated with social impairment among young adolescents with ADHD. J Atten Disord 22(1):66–82
Sibley MH, Evans SW, Serpell ZN (2010) Social cognition and interpersonal impairment in young adolescents with ADHD. J Psychopathol Behav Assess 32:93–202
Funding
This research was supported by award number R305A160126 from the Institute of Education Sciences (IES), U.S. Department of Education. When data reported in this study were collected, Stephen Becker was supported by Award Number K23MH108603 from the National Institute of Mental Health (NIMH). Dr. Wiggs's effort on this project was supported by the National Research Service Award in Primary Medical Care, T32HP10027, through the Health Resources and Services Administration (HRSA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the IES, NIMH, or HRSA.
Author information
Authors and Affiliations
Contributions
Author 1 was responsible for project idea, data cleaning and analysis, interpretation of results, and writing and editing the manuscript. Author 2 helped in data collection and editing of the manuscript. Authors 3 and 5 secured funding for the project, oversaw overall project design and data collection, and helped with editing of the manuscript. Author 4 helped with data analytic plan and editing of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Wiggs discloses grant funding (F31) from the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Breaux discloses research support from the American Psychological Association, 4-VA, Society for a Science of Clinical Psychology, Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Young Scientist Research Fund Award, the Center for Emotional Health (CEH) Emotional Health Research Excellence Award, Virginia Tech Center for Peace Studies and Violence Prevention, and Virginia Tech Institute for Society, Culture, and Environment. Dr. Langberg discloses grant funding from the National Institute on Drug Abuse (NIDA) and the Institute of Education Sciences (IES), and has received book royalties from the National Association for School Psychologists (NASP) and editorial honoraria as Associate Editor and Editor of Research on Child and Adolescent Psychopathology. Dr. Becker discloses grant funding from the Institute of Education Sciences (IES), U.S. Department of Education; National Institute of Mental Health (NIMH); and Cincinnati Children’s Research Foundation (CCRF), and has received book honoraria from Guilford Press, editorial honoraria as Joint Editor of JCPP Advances, grant review panel honoraria from the IES, and educational seminar speaking fees and CE course royalties from J&K Seminars. Dr. Peugh has no disclosures to report.
Ethical approval
The study was approved by the Virginia Commonwealth University and the Cincinnati Children’s Hospital Medical Center Institutional Review Boards.
Informed consent/consent to publish
We obtained written informed consent and assent from participants to participate in this study and use their de-identified data in analysis and publications.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wiggs, K.K., Breaux, R., Langberg, J.M. et al. Examining daily stimulant medication use and sleep in adolescents with ADHD. Eur Child Adolesc Psychiatry 33, 821–832 (2024). https://doi.org/10.1007/s00787-023-02204-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-023-02204-w